Cargando…

Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis

INTRODUCTION: Ibrutinib is an oral covalent inhibitor of Bruton's tyrosine kinase approved for the treatment of patients with chronic lymphocytic leukemia (CLL), mantle cell lymphoma and Waldenstrӧm’s macroglobulinemia. Ibrutinib has an increased risk of atrial fibrillation but the mechanism is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caldeira, Daniel, Alves, Daniela, Costa, João, Ferreira, Joaquim J., Pinto, Fausto J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382095/ https://www.ncbi.nlm.nih.gov/pubmed/30785921 http://dx.doi.org/10.1371/journal.pone.0211228

Ejemplares similares

The effect of catheter-based sham renal denervation in hypertension: systematic review and meta-analysis
por: Fernandes, Adriana, et al.
Publicado: (2023)

Direct oral anticoagulants vs vitamin K antagonist on dementia risk in atrial fibrillation: systematic review with meta-analysis
por: Branco, Diogo R., et al.
Publicado: (2023)

Morphine in acute coronary syndrome: systematic review and meta-analysis
por: Duarte, Gonçalo Silva, et al.
Publicado: (2019)

Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis
por: Caldeira, Daniel, et al.
Publicado: (2022)

The sham effect of invasive interventions in chronic coronary syndromes: a systematic review and meta-analysis
por: Palma, Catarina, et al.
Publicado: (2022)

How to Manage Atrial Fibrillation Secondary to Ibrutinib
por: Essa, Hani, et al.
Publicado: (2021)

Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis
por: Caldeira, Daniel, et al.
Publicado: (2017)

High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019)

Ibrutinib-associated atrial fibrillation treatment with catheter ablation
por: Kapoor, Ridhima, et al.
Publicado: (2021)

Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis
por: Koval, Nazariy, et al.
Publicado: (2021)

Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk
por: Stühlinger, Markus C., et al.
Publicado: (2019)

5-Methoxytryptophan alleviates atrial structural remodeling in ibrutinib-associated atrial fibrillation
por: Shuai, Wei, et al.
Publicado: (2023)

Does Parkinson's Disease Increase the Risk of Atrial Fibrillation? Insights From Electrocardiogram and Risk Scores From a Case-Control Study
por: Alves, Mariana, et al.
Publicado: (2021)

Management of Atrial Fibrillation in Patients on Ibrutinib: A Cleveland Clinic Experience
por: Khalid, Sidra, et al.
Publicado: (2018)

Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study
por: Reda, Gianluigi, et al.
Publicado: (2018)

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
por: Brown, Jennifer R., et al.
Publicado: (2017)

Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis
por: Caldeira, Daniel, et al.
Publicado: (2020)

Enhanced cardiomyocyte reactive oxygen species signaling promotes ibrutinib-induced atrial fibrillation
por: Yang, Xinyu, et al.
Publicado: (2020)

Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis
por: Rodrigues, Filipe Brogueira, et al.
Publicado: (2016)

Antithrombotic Therapy Recommendations in the European Society of Cardiology Guidelines: How Robust Are the Randomized Controlled Trials Underpinning Them?
por: Santos, Catarina M. dos, et al.
Publicado: (2021)

Systematic reviews and meta-analysis published in indexed Portuguese medical journals: time trends and critical appraisal
por: Prada, Luísa, et al.
Publicado: (2022)

Clinical Impact of Atrial Fibrillation in Patients with Pulmonary Hypertension
por: Rottlaender, Dennis, et al.
Publicado: (2012)

Hyperuricemia Increases the Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Gao, Zheng, et al.
Publicado: (2022)

Low-Dose Colchicine in Coronary Artery Disease　― Systematic Review and Meta-Analysis ―
por: Abrantes, Ana Mafalda, et al.
Publicado: (2021)

Atrial Fibrillation and Non-cardiovascular Diseases: A Systematic Review
por: Ferreira, Cátia, et al.
Publicado: (2015)

Management of arterial hypertension: Challenges and opportunities
por: Silva, Beatriz V., et al.
Publicado: (2022)

Atrial Fibrillation in Hypertension: Patients’ Characteristics
por: Koutsaki, Styliani, et al.
Publicado: (2018)

Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies
por: Aune, Dagfinn, et al.
Publicado: (2023)

Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
por: Roeker, Lindsey E., et al.
Publicado: (2019)

Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib
por: Avalon, Juan Carlo, et al.
Publicado: (2021)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
por: Ma, Haotian, et al.
Publicado: (2021)

The atrial fibrillation paradox -connecting hypertension to atrial disease and stroke
por: Mendys, Phil, et al.
Publicado: (2021)

Blood pressure variability in Parkinson's Disease patients – Case control study
por: Alves, Mariana, et al.
Publicado: (2023)

The Accuracy of Hestia and Simplified PESI to Predict the Prognosis in Pulmonary Embolism: Systematic Review with Meta-analysis
por: Palas, Miguel, et al.
Publicado: (2022)

Is ablation to atrial fibrillation termination of persistent atrial fibrillation the end point?: A systematic review and meta-analysis
por: Li, Fanghui, et al.
Publicado: (2019)

Distinct Effects of Ibrutinib and Acalabrutinib on Mouse Atrial and Sinoatrial Node Electrophysiology and Arrhythmogenesis
por: Tuomi, Jari M., et al.
Publicado: (2021)

The association of coagulation and atrial fibrillation: a systematic review and meta-analysis
por: Tilly, Martijn J, et al.
Publicado: (2022)

Acute Effects of Ibrutinib on Ventricular Arrhythmia in Spontaneously Hypertensive Rats
por: Du, Beibei, et al.
Publicado: (2020)

Disturbed Left Atrial Function is Associated with Paroxysmal Atrial Fibrillation in Hypertension
por: Tenekecioglu, Erhan, et al.
Publicado: (2014)

The Impact of Hypertension and Atrial Fibrillation on Cognitive Decline and Subclinical Atherosclerosis
por: Militaru, Marius, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o5j21epg3ch73ks1h4po3b097v